Consistent with this finding an earlier study in the TRAIL-resistant NSCLC cell line, A549, reported that compared to wildtype TRAIL, RGD-TRAIL was more cytotoxic. The gene discussed is TNFSF10; the disease is non-small cell lung carcinoma.